ANNE GREER: Open Payments
NPI 1194422477 · WOODBRIDGE, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,215 in 64 payments from 9 companies in 2025. Trend: 2023 $880 · 2024 $1,650 · 2025 $1,215
Food & beverage: $1,215
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 17 | $213 |
| ABBVIE INC. | 8 | $207 |
| Ardelyx, Inc. | 11 | $185 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 9 | $179 |
| GENZYME CORPORATION | 8 | $174 |
| Janssen Biotech, Inc. | 6 | $151 |
| Regeneron Healthcare Solutions, Inc. | 3 | $60 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Exact Sciences Corporation | 1 | $23 |
Products named: DUPIXENT, VOQUEZNA, IBSRELA, XIFAXAN, RINVOQ, TREMFYA, SKYRIZI, LINZESS.
Industry payments across VA — which companies pay providers there.
